RetinaLyze International

Hjem
Danmark
Skovlunde
RetinaLyze International

Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine.

17/09/2026

Screening finds the suspicious case. Then what?

That question sits at the centre of a new cooperation we're announcing today with Eys, a Norwegian provider of digital ophthalmic workflows and telemedicine.

Eys will now sell RetinaLyze together with its telemedicine solution. For an optometrist, that means one connected pathway: AI-supported retinal screening in the practice, and when a finding needs a second look, a direct route to an ophthalmologist. No stitching together separate vendors. No building your own specialist network.

For chains, the combined offering supports the same workflow across every location. For independent practices, it's a manageable way to add screening and specialist access without adding complexity.

As our CEO Teddy Birch Petersen put it, the value isn't another AI tool. It's a clear next step when something needs further assessment. Sondre Enger Beckrøge, CEO of EYS, made a similar point: optometrists can take a bigger role in eye health if the route to specialist expertise is simple for both practice and patient.

We'll be working with EYS on the commercial and technical rollout over the coming months.

Where does your referral pathway break down today: at the screening, or at the handover?

hashtag hashtag

15/09/2026

Last day of ESCRS 2026!

If you haven't yet seen RetinaLyze running inside Topcon Harmony, booth A.150 is open until the exhibition closes today.

Thanks to Topcon (Great Britain) Medical for including us on the stand, and to everyone who stopped by over the week. If you missed it or want a closer look at any of our new device integrations, book a demo with us and we'll take it from there.

13/09/2026

Timed with ESCRS, we're releasing a round of new device integrations for RetinaLyze. Images from the following cameras can now be sent straight to the RetinaLyze platform for AI screening:
- iCare DRS Plus
- Volk Optical Inc. Viva
- Phelcom Technologies Eyer & Eyer II
- Optovue iCam
- MediWorks FC162
- Huvitz_official HFC-1 & HOCT-1/1F
- ZEISS Medical Technology Visuref 1000

The aim is simple: whatever fundus camera is already in your clinic, RetinaLyze should fit into the workflow without extra steps. Combined with the Topcon Healthcare Harmony integration being shown at ESCRS, this is the widest range of devices we've supported so far.

Details on setup for each device are in our helpdesk, or get in touch and we'll walk you through it.

11/09/2026

ESCRS 2026 opens in London today. To everyone attending, presenting, exhibiting or catching up with colleagues over the next five days: have a great congress.

We'll be following along from Denmark, and RetinaLyze is on display at Topcon's booth A.150 for anyone who wants to see it running in Harmony.

09/09/2026

We won't have our own stand at ESCRS this year, but you can still see RetinaLyze in action in London.

Topcon (Great Britain) Medical is demonstrating RetinaLyze inside Topcon Harmony at booth A.150 from 11 to 15 September.

Capture a fundus image on a Topcon device, and the AI screening result for signs of eye disease like diabetic retinopathy, AMD and glaucoma lands directly in Harmony.

No separate upload, no extra system to log into.

If you're heading to ESCRS, stop by A.150 and ask the Topcon team to show you the workflow.

07/09/2026

Between 40% and 75% of new glaucoma referrals could have been stopped before they ever reached a hospital.

That's the College of Optometrists clinical adviser's wording, back in April. Hospital-only glaucoma pathways are "no longer viable." Glaucoma already accounts for 20-25% of hospital eye service activity.

Nearly every screening algorithm is tuned for sensitivity. Catch everything, miss nothing. It sounds like the safe choice.

It isn't, when the hospital is the bottleneck. A tool that flags every borderline disc doesn't reduce work. It relocates it. Somebody else's clinic absorbs the false positives, and the patients who actually needed that slot wait longer.

Specificity is the number that decides whether you helped or just forwarded the problem.

In May, a university glaucoma service in São Paulo published an independent evaluation of our algorithm (Laguna ONhE, the engine behind RetinaLyze Glaucoma) in PLOS One. 370 eyes. No vendor involvement, no funding, no competing interests.

95% specificity. 97% positive predictive value.

The authors described the algorithm as favouring specificity. It's how the index was built. Its zero point is calibrated to roughly 95% specificity on purpose.

And yes! That has a price. Our sensitivity in that cohort was 69%. We'd rather tell you that than let you find it in Table 5.

When the tool says glaucoma, it is right 97 times in 100. That is the number that lets you keep a patient in your own chair with a clear conscience, and send the one who needs to go with a referral the hospital will thank you for.

Sensitivity protects the patient in front of you. Specificity protects everyone in the queue behind them.

02/09/2026

Ask a chain's clinical director about screening quality and they'll tell you about their best store.

Ask about the twelfth-best. The conversation changes.

Variance is the real problem in a network. Not whether screening can be done well. It clearly can! Whether it's done the same way in Aarhus on a Tuesday and in Milan on a Saturday. By someone three weeks into the job. At five o'clock, when it's been a long day.

Chains don't lose on their ceiling. They lose on their floor.

That's the argument for automating the read rather than the capture. When the analysis takes 45 seconds and comes back the same every time, your variable is the image, not the interpretation. And image quality is a training problem. You can manage that.

Across 7 million screenings, consistency is what multi-site groups actually raise with us. More than accuracy.

It changes the commercial picture too. Screening stops being something your strongest practitioners offer and becomes something the network does. That's the version that shows up in a P&L.

If you run multi-site: what's the spread between your best and worst store? And do you measure it?

31/08/2026

The EU AI Act deadline passed. Plenty of eye care practices spent August worrying about a date that doesn't apply to them.

Screening software is a medical device. That puts it under Annex I. And the high-risk rules in Article 6(1) don't kick in until August 2027. Your CE-marked tool didn't stop being compliant this month. You're fine!

But there is a rule that's already live, and almost nobody mentions it. AI literacy.

Since February 2025, if you deploy an AI system, you have to make sure your people understand it. What it does. What it doesn't. How to read what comes back. You can't buy that from a vendor. It's a training record for the optometrist, the technician, and whoever ends up explaining a yellow result to a nervous patient.

We built RetinaLyze around that. Colour-coded results a trained operator reads in seconds. A clear referral route when they shouldn't be reading it alone. Documentation that holds up in an audit.

So the question for your vendor isn't "are you compliant?" It's "what do I need to prove about my own staff?"

Has your practice done anything about AI literacy yet? Most haven't.

26/08/2026

You are often the first person who gets a proper look at the retina.

Not when the patient is already in the hospital system.
Not when symptoms have become obvious.
But during a routine visit, where the patient may simply be there for new glasses, contact lenses, or a general eye check.

That position matters more than it is sometimes given credit for.
As an optometrist, you are not expected to diagnose every retinal disease. But you are often in the best position to notice when something does not look right.

A small haemorrhage.
An unusual optic nerve head.
Macular changes.
Poor image quality that needs repeating.
A symptom that does not match the image.

These are the moments where good screening makes a difference. Not because every finding is dramatic or every patient needs referral.

But because someone looked carefully, asked the right questions, and made sure the next step was not left to chance.

AI-supported retinal screening can help structure that process.
But the clinical awareness starts with you.

24/08/2026

Sometimes the most important part of a retinal image is what wasn’t visible on the previous one.

This left-eye case shows a retinal detachment with pale, wave-like folds across the detached retina, creating an almost sand-dune-like pattern.

What makes the case particularly interesting is the comparison. Just three weeks earlier, the 45° central fundus images showed no visible signs of retinal detachment.

It is a useful reminder of the limitations of a central fundus image. A retinal detachment may begin outside the captured field, and the picture can change significantly over a relatively short period of time.

That is why symptoms, clinical history and peripheral assessment still matter, even when a recent central image looked unremarkable.

Adresse

Lyskær 1
Skovlunde
2730

Hvad er åbningstiderne?

Mandag	09:00 - 17:30
Tirsdag	09:00 - 17:30
Onsdag	09:00 - 17:30
Torsdag	09:00 - 17:30
Fredag	09:00 - 17:30

Internet side

https://retinalyze.com/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når RetinaLyze International sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til RetinaLyze International:

Vil du plassere din praksis på toppen av Klinik-listen i Skovlunde?